NYSE : PBH

Prestige Consumer Healthcare Inc. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 49.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.32B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Prestige Consumer Healthcare Inc. (PBH) reported revenue of 1.10B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Operating Revenue1.10B1.08B1.14B1.13B1.13B1.09B
Other Revenue9.08M3.96M1.18M311.00K107.00K42.00K
Revenue1.10B1.09B1.14B1.13B1.13B1.09B
Cost of Revenue499.70M482.79M494.42M492.79M494.88M458.94M
Gross Profit605.18M605.91M643.35M632.57M632.84M627.87M
Selling, General & Admin279.81M265.23M263.93M259.47M252.41M259.70M
Operating Expenses312.17M296.50M294.11M290.14M285.04M291.79M
Operating Income293.01M309.41M349.24M342.43M347.80M336.08M
Interest Expense-46.08M-42.34M-47.63M-67.16M-69.16M-64.29M
Other Non Operating Income (Expenses)-9.83M-9.57M-4.95M756.00K-2.34M-1.05M
EBT Excluding Unusual Items237.10M257.50M296.65M276.02M276.30M270.74M
Merger & Restructuring Charges-2.84M-5.10M
Impairment of Goodwill-48.80M-300.00K
Asset Writedown-12.47M-321.42M-757.00K
Other Unusual Items-2.12M
Pretax Income234.26M257.50M284.19M276.02M-93.92M262.46M
Income Tax Expense62.25M67.19M69.58M66.69M-11.61M57.08M
Net Income172.01M190.30M214.60M209.34M-82.31M205.38M
Net Income to Common172.01M190.30M214.60M209.34M-82.31M205.38M
Shares Outstanding (Basic)47.95M48.46M49.70M49.76M49.89M50.26M
Shares Outstanding (Diluted)48.16M48.72M50.08M50.18M49.89M50.84M
EPS (Basic)3.593.934.324.21-1.654.09
EPS (Diluted)3.583.914.294.17-1.654.04
Free Cash Flow235.36M246.45M243.29M239.38M221.93M250.28M
Free Cash Flow Per Share4.895.064.864.774.454.92
Gross Margin54.77%55.65%56.55%56.21%56.12%57.77%
Operating Margin26.52%28.42%30.70%30.43%30.84%30.92%
Profit Margin15.57%17.48%18.86%18.60%-7.30%18.90%
Free Cash Flow Margin21.30%22.64%21.38%21.27%19.68%23.03%
EBITDA325.37M340.68M379.41M373.10M380.43M368.17M
EBITDA Margin29.45%31.29%33.35%33.15%33.73%33.88%
D&A For EBITDA32.36M31.27M30.17M30.68M32.62M32.09M
EBIT293.01M309.41M349.24M342.43M347.80M336.08M
EBIT Margin26.52%28.42%30.70%30.43%30.84%30.92%
Effective Tax Rate26.57%26.10%24.48%24.16%21.75%
Revenue as Reported1.10B1.09B1.14B1.13B1.13B1.09B
Advertising Expenses148.78M155.72M153.31M145.06M157.34M

Balance sheet

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents89.13M63.87M97.88M46.47M58.49M27.18M
Cash & Short-Term Investments89.13M63.87M97.88M46.47M58.49M27.18M
Accounts Receivable187.35M190.38M185.73M168.65M167.02M139.33M
Other Receivables1.54M768.00K2.06M
Receivables187.35M191.92M194.29M176.78M167.02M139.33M
Inventory190.22M159.13M147.71M138.72M162.12M120.34M
Prepaid Expenses30.12M16.56M8.44M13.08M4.12M6.41M
Total Current Assets496.81M431.48M448.33M375.04M391.74M293.27M
Property, Plant & Equipment164.17M171.25M127.84M89.33M89.53M98.53M
Goodwill650.79M581.11M527.42M527.73M527.55M578.98M
Other Intangible Assets3.24B2.30B2.30B2.32B2.34B2.70B
Long-Term Deferred Tax Assets8.70M800.00K2.40M1.90M
Other Long-Term Assets13.43M2.17M2.47M3.33M1.10M3.27M
Total Assets4.57B3.49B3.40B3.32B3.35B3.67B
Accounts Payable36.85M22.79M18.93M38.98M62.74M55.76M
Accrued Expenses85.59M84.85M78.33M69.35M77.57M75.89M
Short-Term Debt3.64M2.99M
Current Portion of Long-Term Debt10.45M
Current Portion of Leases9.71M9.57M8.54M6.15M9.76M9.11M
Current Income Taxes Payable7.57M733.00K830.00K2.57M10.64M2.66M
Total Current Liabilities153.81M120.92M106.62M117.05M160.72M143.42M
Long-Term Debt2.01B993.95M992.36M1.13B1.35B1.48B
Long-Term Leases36.41M38.92M43.36M7.70M11.54M20.59M
Pension & Post-Retirement Benefits2.73M2.87M3.02M3.28M
Long-Term Deferred Tax Liabilities448.82M447.42M419.59M403.60M380.43M444.92M
Other Long-Term Liabilities5.59M2.85M2.52M6.17M4.88M7.48M
Total Liabilities2.65B1.61B1.57B1.66B1.91B2.09B
Common Stock563.00K562.00K560.00K555.00K548.00K544.00K
Additional Paid-In Capital612.51M608.52M593.40M567.45M535.36M515.58M
Retained Earnings1.78B1.75B1.56B1.34B1.13B1.21B
Treasury Stock-441.96M-439.30M-277.21M-219.62M-189.11M-133.65M
Comprehensive Income & Other-29.68M-28.37M-37.66M-34.49M-31.56M-19.03M
Shareholders' Equity1.92B1.89B1.83B1.66B1.45B1.58B
Total Liabilities & Equity4.57B3.49B3.40B3.32B3.35B3.67B
Total Debt2.07B1.05B1.04B1.14B1.37B1.51B
Net Cash (Debt)-1.98B-981.56M-946.37M-1.09B-1.31B-1.48B
Net Cash Per Share-41.08-20.15-18.90-21.79-26.23-29.09
Filing Date Shares Outstanding47.37M47.37M49.41M49.92M49.69M50.28M
Total Common Shares Outstanding47.37M47.32M49.51M49.82M49.69M50.28M
Working Capital343.01M310.56M341.70M258.00M231.03M149.84M
Book Value Per Share40.4639.8937.0633.2229.1231.38
Tangible Book Value-1.98B-993.20M-987.88M-1.19B-1.42B-1.70B
Tangible Book Value Per Share-41.74-20.99-19.95-23.95-28.62-33.77
Land2.14M550.00K550.00K550.00K550.00K
Buildings48.86M31.35M31.01M30.45M29.05M
Machinery120.52M109.92M104.34M80.28M76.87M
Construction In Progress28.24M3.35M2.41M17.09M16.47M
Leasehold Improvements10.81M10.61M10.55M9.04M9.08M

Cash flow statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income172.01M190.30M214.60M209.34M-82.31M205.38M
Depreciation & Amortization32.36M31.27M30.17M30.68M32.62M32.09M
Other Amortization1.82M1.80M1.75M5.24M4.36M4.23M
Loss (Gain) From Sale of Assets356.00K165.00K234.00K274.00K273.00K271.00K
Asset Writedown & Restructuring Costs12.47M370.22M1.06M
Stock-Based Compensation11.15M10.84M11.16M14.01M12.40M9.04M
Other Operating Activities27.66M30.55M23.07M29.22M-54.01M18.80M
Change in Accounts Receivable-27.58M-3.69M-16.33M-6.32M-24.93M-24.65M
Change in Inventory16.00K-1.60M-9.31M24.44M-42.23M663.00K
Change in Accounts Payable10.50M-151.00K-19.41M-24.97M7.26M9.15M
Change in Other Net Operating Assets10.78M-12.19M3.11M-32.98M6.04M3.89M
Operating Cash Flow249.40M257.63M251.51M248.93M229.72M259.92M
Capital Expenditures-14.04M-11.18M-8.22M-9.55M-7.78M-9.64M
Cash Acquisitions-1.17B-123.74M-8.25M-10.56M-3.80M-246.87M
Other Investing Activities-15.86M-1.93M-978.00K
Investing Cash Flow-1.20B-136.84M-17.45M-20.11M-11.58M-256.51M
Short-Term Debt Issued42.99M20.00M85.00M
Long-Term Debt Issued597.00M
Total Debt Issued1.09B42.99M20.00M682.00M
Short-Term Debt Repaid-40.00M-20.00M-85.00M
Long-Term Debt Repaid-2.48M-139.54M-227.83M-137.75M-602.58M
Total Debt Repaid-42.45M-42.48M-139.54M-227.83M-157.75M-687.58M
Net Debt Issued (Repaid)1.05B504.00K-139.54M-227.83M-137.75M-5.58M
Issuance of Common Stock1.13M4.29M14.80M18.09M7.37M7.04M
Repurchase of Common Stock-124.44M-160.60M-57.34M-30.51M-55.47M-2.92M
Other Financing Activities-24.21M-246.00K-769.00K-6.11M
Financing Cash Flow898.67M-156.06M-182.07M-241.01M-185.85M-7.57M
Foreign Exchange Rate Adjustments189.00K1.26M-573.00K180.00K-982.00K-959.00K
Net Cash Flow-50.38M-34.02M51.41M-12.02M31.30M-5.12M
Free Cash Flow235.36M246.45M243.29M239.38M221.93M250.28M
Free Cash Flow Margin21.30%22.64%21.38%21.27%19.68%23.03%
Free Cash Flow Per Share4.895.064.864.774.454.92
Levered Free Cash Flow147.89M192.76M188.69M177.04M165.23M200.02M
Unlevered Free Cash Flow174.87M217.42M216.70M213.77M204.10M235.97M
Cash Interest Paid43.72M43.84M47.80M63.25M54.24M61.36M
Cash Income Tax Paid44.68M45.94M52.12M59.64M40.74M46.57M
Change in Working Capital-6.29M-17.62M-41.94M-39.83M-53.85M-10.95M

Ratios

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization2.32B2.80B4.26B3.60B3.11B2.66B
Enterprise Value4.30B3.82B5.24B4.75B4.47B4.20B
Last Close Price49.0659.2785.9772.5662.6352.94
PE Ratio13.7214.7419.8417.2112.94
Forward PE10.4412.5817.9015.8914.5312.82
PS Ratio2.102.583.743.202.762.44
PB Ratio1.211.492.322.182.151.69
P/FCF Ratio9.8811.3817.5015.0514.0210.62
P/OCF Ratio9.3210.8916.9314.4713.5510.22
PEG Ratio1.301.802.331.871.711.51
EV/Sales Ratio3.893.514.604.223.973.86
EV/EBITDA Ratio13.2211.2213.8012.7411.7611.40
EV/EBIT Ratio14.6812.3514.9913.8812.8612.49
EV/FCF Ratio18.2815.5121.5219.8520.1616.77
Debt / Equity Ratio1.080.550.570.690.940.95
Debt / EBITDA Ratio5.862.842.362.593.063.61
Debt / FCF Ratio8.784.244.294.766.166.02
Net Debt / Equity Ratio1.030.520.520.660.900.94
Net Debt / EBITDA Ratio6.082.882.492.933.444.02
Net Debt / FCF Ratio8.413.983.894.575.905.91
Asset Turnover0.280.320.340.340.320.31
Inventory Turnover2.913.153.453.283.503.90
Quick Ratio1.802.122.671.851.401.16
Current Ratio3.233.574.213.202.442.04
Return on Equity (ROE)9.12%10.22%12.30%13.50%-5.44%13.99%
Return on Assets (ROA)4.58%5.61%6.50%6.42%6.19%5.92%
Return on Invested Capital (ROIC)6.36%8.09%9.54%9.44%11.97%8.91%
Return on Capital Employed (ROCE)6.60%9.20%10.60%10.70%10.90%9.50%
Earnings Yield7.29%6.78%5.04%5.81%-2.65%7.73%
FCF Yield10.13%8.79%5.71%6.64%7.13%9.42%
Buyback Yield / Dilution3.62%2.72%0.19%-0.58%1.87%-0.47%